WASHINGTON (Reuters) – The U.S. Food and Drug Administration will act as soon as possible on Moderna Inc’s application seeking approval of its COVID-19 vaccine for children under age 5, the agency’s chief told lawmakers on Thursday.
“There’s no delay in Moderna’s application,” FDA Commissioner Robert Califf told a U.S. House Agriculture subcommittee, adding the agency was preparing for public hearings on the company’s bid “as quickly as possible.”
Source: Read Full Article